Provision of Nasal Naloxone

Open

Buyers

Katy Reed

Value

£3,000,000

Classifications

Pharmaceutical products

Submission Deadline

3 weeks from now

Published

1 day ago

Description

The provision including supply and delivery of nasal Naloxone. Nasal Naloxone supplied must be licensed for use in the UK, compliant with Medicines and Healthcare products Regulatory Agency (MHRA) standards and of a formulation licensed for use on adults and adolescents aged 14 and over. Timely delivery is required to HMPPS settings across England and Wales, including Public Sector (HMPPS) and Privately Managed Prisons, Youth Custody sites, Approved Premises (AP), Independent Approved Premises (IAPs), and Probation Offices and contact centers.

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

Contract Agreement

The official contract terms, conditions, and scopes of work.

Download
Award Notice

Details on the tender award and selected suppliers.

Download